Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tegaserod

🥰Excellent
Catalog No. T60680Cas No. 145158-71-0

Tegaserod is an orally available 5-HT4R agonist and 5-HT2B receptor antagonist with inhibitory effects on various 5-hydroxytryptamine receptors. Tegaserod has antitumor activity and is used in the treatment of irritable bowel syndrome (IBS).

Tegaserod

Tegaserod

🥰Excellent
Purity: 99.89%
Catalog No. T60680Cas No. 145158-71-0
Tegaserod is an orally available 5-HT4R agonist and 5-HT2B receptor antagonist with inhibitory effects on various 5-hydroxytryptamine receptors. Tegaserod has antitumor activity and is used in the treatment of irritable bowel syndrome (IBS).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$31In StockIn Stock
5 mg$46In StockIn Stock
10 mg$64In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.89%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Tegaserod is an orally available 5-HT4R agonist and 5-HT2B receptor antagonist with inhibitory effects on various 5-hydroxytryptamine receptors. Tegaserod has antitumor activity and is used in the treatment of irritable bowel syndrome (IBS).
In vitro
Tegaserod ( 3,5 μM; 24,48,72 h ) increased the apoptosis of A375, RPMI-7951 ( RPMI ), SH4, B16F10, MeWo and MEL-JUSO cell lines in a time- and dose-dependent manner[1].
In vivo
After subcutaneous injection of B16F10 cells in C57BL / 6J mice, tegaserod ( 5 mg / kg ; 1 times a day for 5 consecutive days ) significantly reduced tumor growth, and only a slight decrease in body weight was observed after treatment[1].
Chemical Properties
Molecular Weight301.39
FormulaC16H23N5O
Cas No.145158-71-0
SmilesN=C(NN=CC1=CNC=2C=CC(OC)=CC12)NCCCCC
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 257.5 mg/mL (854.37 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (16.59 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.3180 mL16.5898 mL33.1796 mL165.8980 mL
5 mM0.6636 mL3.3180 mL6.6359 mL33.1796 mL
10 mM0.3318 mL1.6590 mL3.3180 mL16.5898 mL
20 mM0.1659 mL0.8295 mL1.6590 mL8.2949 mL
50 mM0.0664 mL0.3318 mL0.6636 mL3.3180 mL
100 mM0.0332 mL0.1659 mL0.3318 mL1.6590 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tegaserod | purchase Tegaserod | Tegaserod cost | order Tegaserod | Tegaserod chemical structure | Tegaserod in vivo | Tegaserod in vitro | Tegaserod formula | Tegaserod molecular weight